These findings suggest that regulatory dysfunction in ACD extends beyond IL-10 deficiency and involves additional immunomodulatory mechanisms, including direct cell-to-cell contact, which warrant further investigation. The gene discussed is IL10; the disease is granular corneal dystrophy type II.